<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03989154</url>
  </required_header>
  <id_info>
    <org_study_id>RMCZZU-POI cohort study</org_study_id>
    <nct_id>NCT03989154</nct_id>
  </id_info>
  <brief_title>Primary Ovarian Insufficient Patients</brief_title>
  <official_title>Prospective Cohort Study for Primary Ovarian Insufficient Patients in Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital of Zhengzhou University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Prospective Cohort Study for Primary Ovarian Insufficient Patients was set up to
      investigate the short- and long-term health consequences in Reproductive Medical Center,
      First Affiliated Hospital of Zhengzhou University, China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Premature ovarian insufficiency (POI) is a rare cause of infertility in women affecting 1% of
      the population. It is characterized by amenorrhea, hypoestrogenism and elevated gonadotrophin
      levels in women younger than 40 years of age. Other than the reproductive outcome of these
      patients, the short- and long-term health consequences are still unknown.

      Since last decade, Clinical Reproductive Medicine Management System/Electronic Medical Record
      Cohort Database (CCRM/EMRCD) has been used in Reproductive Medical Center, First Affiliated
      Hospital of Zhengzhou University, and Henan Province Key Laboratory for Reproduction and
      Genetics. Information of patients (POI, PCOS, Endometriosis, azoospermia, ect) were recorded
      comprehensively. The current project plans to recruit POI participants in our center.
      Biological samples, questionnaires and short/long term health data will be collected. The
      study is aimed to provide evidence for POI prognosis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2010</start_date>
  <completion_date type="Anticipated">December 31, 2050</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2050</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>FSH (Follicle stimulating hormone)</measure>
    <time_frame>Change from Baseline FSH at each6 months</time_frame>
    <description>mIU/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>LH (luteinizing hormone)</measure>
    <time_frame>Change from Baseline LH at each6 months</time_frame>
    <description>mIU/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estrogen</measure>
    <time_frame>Change from Baseline Estrogen at each6 months</time_frame>
    <description>pg/ml</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Progesterone</measure>
    <time_frame>Change from Baseline Progesterone at each6 months</time_frame>
    <description>ng/ml</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Volume of uterus and ovary</measure>
    <time_frame>Change from Baseline volume at each6 months</time_frame>
    <description>Record the Length (mm)*Width (mm)*Height (mm) of uterus, and each ovary</description>
  </secondary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Healthy Related</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        (1) younger than 40 years of age; (2) at least four or more months of amenorrhea, two or
        more instances in which the serum FSH level is &gt; 40 U/L (i.e., two inspections at intervals
        of 1 month or more), with an oestradiol level of &lt;20pg/ml
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  younger than 40 years of age

          -  at least four or more months of amenorrhea, two or more instances in which the serum
             FSH level is &gt; 40 U/L (i.e., two inspections at intervals of 1 month or more), with an
             oestradiol level of &lt;20pg/ml

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lanlan Fang, M.D.</last_name>
    <phone>13673355291</phone>
    <email>fanglly@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450052</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhiqin Bu, M.D.</last_name>
      <phone>15981978863</phone>
      <email>rmczzu@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Kovanci E, Schutt AK. Premature ovarian failure: clinical presentation and treatment. Obstet Gynecol Clin North Am. 2015 Mar;42(1):153-61. doi: 10.1016/j.ogc.2014.10.004. Review.</citation>
    <PMID>25681846</PMID>
  </reference>
  <reference>
    <citation>Zhai J, Yao G, Dong F, Bu Z, Cheng Y, Sato Y, Hu L, Zhang Y, Wang J, Dai S, Li J, Sun J, Hsueh AJ, Kawamura K, Sun Y. In Vitro Activation of Follicles and Fresh Tissue Auto-transplantation in Primary Ovarian Insufficiency Patients. J Clin Endocrinol Metab. 2016 Nov;101(11):4405-4412. Epub 2016 Aug 29.</citation>
    <PMID>27571179</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 13, 2019</study_first_submitted>
  <study_first_submitted_qc>June 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2019</study_first_posted>
  <last_update_submitted>June 18, 2019</last_update_submitted>
  <last_update_submitted_qc>June 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital of Zhengzhou University</investigator_affiliation>
    <investigator_full_name>Yingpu Sun</investigator_full_name>
    <investigator_title>Director of Reproductive Medical Center</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

